Literature DB >> 11838603

Regulation of human growth hormone secretion and its disorders.

Yuzuru Kato1, Yoshio Murakami, Motoi Sohmiya, Masateru Nishiki.   

Abstract

Growth hormone (GH) secretion from anterior pituitary is regulated by the hypothalamus and the mediators of GH actions. Major regulatory factors include GH releasing hormone (GHRH), somatostatin (SRIF), GH releasing peptide (ghrerin) and insulin-like growth factor (IGF-I). The principal physiological regulation mechanisms of GH secretion are neural endogenous rhythm, sleep, stress, exercise, and nutritional and metabolic signals. GH deficiency results from various hereditary or acquired causes, which may be isolated or combined with other pituitary hormone deficiencies. GH deficiency can be treated with recombinant human GH, which results in accelerating growth in children and normalization of intermediary metabolism in adults. GH hypersecretion mostly results from a pituitary tumor and causes acromegaly or gigantism. Hypersecretion of GH can be treated by transshenoidal surgery. Medical treatment with octreotide and analogs is also effective to reduce GH secretion in combination with or without the surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11838603     DOI: 10.2169/internalmedicine.41.7

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  17 in total

1.  Phosphoproteomic analysis of the human pituitary.

Authors:  Sarka Beranova-Giorgianni; Yingxin Zhao; Dominic M Desiderio; Francesco Giorgianni
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

2.  Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.

Authors:  M Castagno; A Monzani; S Zanetta; G Genoni; E Giglione; R Ricotti; G Bona; F Prodam; S Bellone
Journal:  J Endocrinol Invest       Date:  2018-02-08       Impact factor: 4.256

Review 3.  Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

Authors:  Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick
Journal:  Endocr Rev       Date:  2010-12-01       Impact factor: 19.871

Review 4.  Mice with gene alterations in the GH and IGF family.

Authors:  Yanrong Qian; Darlene E Berryman; Reetobrata Basu; Edward O List; Shigeru Okada; Jonathan A Young; Elizabeth A Jensen; Stephen R C Bell; Prateek Kulkarni; Silvana Duran-Ortiz; Patricia Mora-Criollo; Samuel C Mathes; Alison L Brittain; Mat Buchman; Emily Davis; Kevin R Funk; Jolie Bogart; Diego Ibarra; Isaac Mendez-Gibson; Julie Slyby; Joseph Terry; John J Kopchick
Journal:  Pituitary       Date:  2021-11-19       Impact factor: 4.107

Review 5.  Neuroendocrine abnormalities in fibromyalgia.

Authors:  Gail K Adler; Valdis F Manfredsdottir; Katharine W Creskoff
Journal:  Curr Pain Headache Rep       Date:  2002-08

Review 6.  Mouse models of growth hormone deficiency.

Authors:  Edward O List; Reetobrata Basu; Silvana Duran-Ortiz; Jackson Krejsa; Elizabeth A Jensen
Journal:  Rev Endocr Metab Disord       Date:  2020-10-09       Impact factor: 6.514

7.  Association of polymorphisms of exon 2 of the growth hormone gene with production performance in Huoyan goose.

Authors:  Yang Zhang; Zhen Zhu; Qi Xu; Guohong Chen
Journal:  Int J Mol Sci       Date:  2014-01-07       Impact factor: 5.923

8.  Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile.

Authors:  Claudio Pietra; Yasuhiro Takeda; Naoko Tazawa-Ogata; Masashi Minami; Xia Yuanfeng; Elizabeth Manning Duus; Robert Northrup
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-09-30       Impact factor: 12.910

9.  Sparse Deconvolution of Pulsatile Growth Hormone Secretion in Adolescents.

Authors:  Jon X Genty; Md Rafiul Amin; Natalie D Shaw; Elizabeth B Klerman; Rose T Faghih
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2022-08-08       Impact factor: 3.702

Review 10.  Oncology Update: Anamorelin.

Authors:  Eric Prommer
Journal:  Palliat Care       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.